Capex / revenue moved 272 bp lower
Capex / revenue changed -272 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capex / revenue changed -272 basis points from the comparable as-filed period.
Capital expenditure changed -50.0% from the comparable as-filed period.
Operating cash flow changed -234.0% from the comparable as-filed period.
Stock-based compensation changed -182.7% from the comparable as-filed period.
Net income changed +11.7% from the comparable as-filed period.
Free-cash-flow proxy changed +5.5% from the comparable as-filed period.
Inventory changed -9.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating income changed -1.0% from the comparable as-filed period.
Operating margin changed +7 basis points from the comparable as-filed period.
Revenue changed +1.5% from the comparable as-filed period.
Selling, general & administrative changed +3.7% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.